2nd International Conference on Cancer Research & Immuno-Oncology

The 2nd International Conference on Cancer Research & Immuno-Oncology advances interdisciplinary research and clinical collaboration in cancer science, precision oncology, and immuno-oncology to improve patient outcomes.

Key Topics

• Immuno-oncology frontiers
• Precision oncology and biomarker discovery
• CAR-T cell therapy and adoptive T-cell approaches
• Immune checkpoint inhibitors
• Tumor microenvironment biology
• Cancer vaccines and novel immunotherapies
• Cell and gene therapy in oncology
• Antibody-drug conjugates and targeted therapeutics
• Radiotheranostics and targeted radiopharmaceuticals
• Liquid biopsy and minimal residual disease
• Early detection and cancer screening
• AI, imaging, and clinical decision support
• Clinical trial design and innovation
• Real-world data and treatment outcomes
• Treatment resistance and therapy sequencing
• Perioperative and neoadjuvant strategies

Who should Attend

• Oncologists, immunologists, and hematologists
• Cancer researchers and biomedical scientists
• Immunotherapy and precision medicine experts
• Pharmaceutical and biotechnology professionals
• Radiologists, pathologists, and pharmacologists
• Clinical researchers and trial coordinators
• Academic scholars, postdoctoral fellows, and students
• Healthcare policymakers and regulatory professionals